Gracell Biotechnologies to Participate in Oppenheimer 33rd Annual Healthcare Conference

Rhea-AI Summary

Gracell Biotechnologies Inc. (NASDAQ: GRCL) announced its participation in the Oppenheimer 33rd Annual Healthcare Conference from March 13 to 15, 2023. The management team will present on March 14 at 1:20 PM ET and will host investor meetings that day. A live webcast of the presentation will be available on the Company's website, along with a replay for 90 days post-event. Gracell focuses on developing innovative and cost-effective cell therapies for cancer using its proprietary FasTCAR and TruUCAR platforms.

SAN DIEGO Calif., and SUZHOU and SHANGHAI, China, Feb. 28, 2023 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that the management team will participate in the Oppenheimer 33^rd Annual Healthcare Conference from March 13^th to 15^th.  

The Gracell team is scheduled to present on March 14^th at 1:20 pm ET and will host investor meetings at the conference on March 14^th.

A webcast of the presentation will be available on the News and Events  section of the Company's website. A replay of the webcast will be available for 90 days following the event. For more information, please visit ir.gracellbio.com.

About Gracell
Gracell Biotechnologies Inc. ("Gracell") is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms and SMART CART^TM technology module, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal cell quality, high therapy cost and lack of effective CAR-T therapies for solid tumors. For more information on Gracell, please visit http://www.gracellbio.com/. Follow @GracellBio on LinkedIn. 

Media contact
Marvin Tang
marvin.tang@gracellbio.com

Investor contact
Gracie Tong
gracie.tong@gracellbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/gracell-biotechnologies-to-participate-in-oppenheimer-33rd-annual-healthcare-conference-301756162.html

SOURCE Gracell Biotechnologies Inc.

FAQ

When is Gracell participating in the Oppenheimer 33rd Annual Healthcare Conference?

Gracell is participating in the Oppenheimer 33rd Annual Healthcare Conference from March 13 to 15, 2023.

What time will Gracell present at the Oppenheimer conference?

Gracell will present on March 14, 2023, at 1:20 PM ET.

Where can I watch the Gracell conference presentation?

The Gracell conference presentation will be available via a live webcast on their website at the News and Events section.

Will there be a replay of the Gracell presentation?

Yes, a replay of the Gracell presentation will be available for 90 days after the event.

What technologies does Gracell use for cell therapy?

Gracell uses its proprietary FasTCAR and TruUCAR technology platforms to develop cell therapies.